Inappropriate Topical Antibiotics Use in Clean Dermatological Procedures in South Korea in 2018: A Nationwide Population-Based Cross-Sectional Study
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background: The use of topical antibiotics (TA) for prophylactic purposes after clean dermatologic procedures (CDP) is generally not recommended, and the prescription of TA needs to be individualized in consideration of each patient’s situation and underlying disease. The aim of this study was to determine the proportion of patients who underwent CDP in outpatient settings and were prescribed TA inappropriately, as well as the factors that may affect the prescription of TA.Methods: Outpatient visits coded for CDP were selected using claims data from the Health Insurance Review and Assessment Service in 2018. Of these, patients receiving TA prescriptions were classified as having inappropriate TA use, and the proportion was estimated through technical analysis. A logistic regression analysis was used to identify factors influencing inappropriate prescriptions.Results: Data were analyzed using 423,651 visits, and TA was prescribed for approximately 1.9% of the visits. TA us-age was higher among women (2.0%), 0–19 years of age (2.2%), medical aid (2.2%), clinic settings (2.4%), and met-ropolitan areas (2.0%). TA was prescribed more frequently in urology (8.6%), pediatrics (5.0%), and dermatology (4.2%) than in other specialties.Conclusion: The prescription rate of TA after CDP was 1.9% using the 1.4 million patient sample from the national health insurance claims data in Korea, which is equally weighted to represent 50 million people. Although the pro-portion of inappropriate TA prescriptions in Korea is lower than that in other nations, it cannot be overlooked be-cause of the large number of cases. Efforts to improve quality are required to reduce the number of inappropriate prescriptions.
Abstract
Background: The use of topical antibiotics (TA) for prophylactic purposes after clean dermatologic procedures (CDP) is generally not recommended, and the prescription of TA needs to be individualized in consideration of each patient’s situation and underlying disease. The aim of this study was to determine the proportion of patients who underwent CDP in outpatient settings and were prescribed TA inappropriately, as well as the factors that may affect the prescription of TA.Methods: Outpatient visits coded for CDP were selected using claims data from the Health Insurance Review and Assessment Service in 2018. Of these, patients receiving TA prescriptions were classified as having inappropriate TA use, and the proportion was estimated through technical analysis. A logistic regression analysis was used to identify factors influencing inappropriate prescriptions.Results: Data were analyzed using 423,651 visits, and TA was prescribed for approximately 1.9% of the visits. TA us-age was higher among women (2.0%), 0–19 years of age (2.2%), medical aid (2.2%), clinic settings (2.4%), and met-ropolitan areas (2.0%). TA was prescribed more frequently in urology (8.6%), pediatrics (5.0%), and dermatology (4.2%) than in other specialties.Conclusion: The prescription rate of TA after CDP was 1.9% using the 1.4 million patient sample from the national health insurance claims data in Korea, which is equally weighted to represent 50 million people. Although the pro-portion of inappropriate TA prescriptions in Korea is lower than that in other nations, it cannot be overlooked be-cause of the large number of cases. Efforts to improve quality are required to reduce the number of inappropriate prescriptions.
참고문헌 (34)
- Nguyen JK, "Variability in wound care recommendations following dermatologic procedures", Dermatol Surg, 46, pp.186~191 (2020)
- Fathy R, "Variation in topical antibiotics recommendations in wound care instructions by non-dermatologists", J Gen Intern Med, 36, pp.238~239 (2021)
- Totoraitis K, "Topical approaches to improve surgical outcomes and wound healing : a review of efficacy and safety", J Drugs Dermatol, 16, pp.209~212 (2017)
- Saco M, "Topical antibiotic prophylaxis for prevention of surgical wound infections from dermatologic procedures : a systematic review and meta-analysis", J Dermatolog Treat, 26, pp.151~158 (2015)
- Smack DP, "Infection and allergy incidence in ambulatory surgery patients using white petrolatum vs bacitracin ointment : a randomized controlled trial", JAMA, 276, pp.972~977 (1996)
- "Choosing wisely"[URL]
- "Choosing wisely: don’t routinely use topical antibiotics on a surgical wound"[URL]
- Levender MM, "Use of topical antibiotics as prophylaxis in clean dermatologic procedures", J Am Acad Dermatol, 66, pp.445~451 (2012)
- Lapolla WJ, "Topical antibiotic trends from 1993 to 2007 : use of topical antibiotics for non-evidence-based indications", Dermatol Surg, 37, pp.1427~1433 (2011)
- Fathy R, "The frequency of topical antibiotic use after biopsy and excision procedures among dermatologists and nondermatologists : 2006 through 2015", J Am Acad Dermatol, 82, pp.1258~1261 (2020)
- Barbieri JS, "Use of antibiotics for dermatologic procedures from 2008 to 2016", JAMA Dermatol, 155, pp.465~470 (2019)
- Ferguson J, "Recent trends in the prescribing of antibiotics", Prescriber, 12, pp.59~62 (2001)
- Eady AE, "Is antibiotic resistance in cutaneous propionibacteria clinically relevant? : implications of resistance for acne patients and prescribers", Am J Clin Dermatol, 4, pp.813~831 (2003)
- Garner JS, "CDC guideline for prevention of surgical wound infections, 1985 : supersedes guideline for prevention of surgical wound infections published in 1982(originally published in November 1985) : revised", Infect Control, 7, pp.193~200 (1986)
- Rogers HD, "Reply", J Am Acad Dermatol, 65, pp.203~ (2011)
- Ock M, "Perceptions of primary care in Korea : a comparison of patient and physician focus group discussions", BMC Fam Pract, 15, pp.178~ (2014)
- Chun CB, "Republic of Korea: health system review", Health Syst Transit, 11, pp.1~184 (2009)
- Kwon S, "Payment system reform for health care providers in Korea", Health Policy Plan, 18, pp.84~92 (2003)
- Song YJ, "The South Korean health care system", Japan Med Assoc J, 52, pp.206~209 (2009)
- Kim HJ, "Pharmaceutical reform in South Korea and the lessons it provides", Health Aff(Millwood), 27, pp.w260~w269 (2008)
- "A study for the establishment of separation of prescription and dispensing" (2001)[URL]
- "Health insurance statistics"[URL]
- Noh JW, "Gender differences in outpatient utilization: a pooled analysis of data from the Korea Health Panel", J Womens Health (Larchmt), 26, pp.178~185 (2017)
- Shin SM, "Medical aid service overuse assessed by case managers in Korea", J Adv Nurs, 66, pp.2257~2265 (2010)
- Kwon S, "Republic of Korea health system review", World Health Organization, Regional Office for the Western Pacific, ~ (2015)
- "NHI Program"[URL]
- "Initial country-level information about socio-economic differences in health, nutrition and population" (2003)[URL]
- Kazemian A, "How much dentists are ethically concerned about overtreatment : a vignette-based survey in Switzerland", BMC Med Ethics, 16, pp.43~ (2015)
- Katz MH, "Undertreatment improves, but overtreatment does not", JAMA Intern Med, 173, pp.93~ (2013)
- Torjuul K, "Action ethical dilemmas in surgery : an interview study of practicing surgeons", BMC Med Ethics, 6, pp.E7~ (2005)
- 정유석, "무엇이 과잉진료를 부추기는가?: 과잉진료의 원인 고찰과 대책", 한국의료윤리학회지, 19(3), pp.375~389 (2016), 한국의료윤리학회[DOI]
- 박재영, "History of Investigative and Clinical Urology and an analysis of published articles", Investigative and Clinical Urology, 61, pp.64~69 (2020), 대한비뇨의학회[DOI]
- Kee CD, "The history of urology in Korea(1910-1945)", Korean J Med Hist, 6, pp.231~269 (1997)
- 최재기, "History of Syphilis and Gonorrhea in Korea", Infection and Chemotherapy, 51(2), pp.210~216 (2019), 대한감염학회[DOI]